TABLE 2.
Validation of non-live birth outcome algorithms
| Analysis | No. of cases reviewed | % retained | No. of true cases | % retained | PPV (95% CI), % |
|---|---|---|---|---|---|
| Stillbirth | |||||
| Primary definition: ≥ 1 inpatient codes | 100 | 71 | 71.0 (61.1–79.6) | ||
| Exclude cases with codes for other pregnancy outcomes within ±5 days | 72 | 72.0% | 58 | 81.7% | 80.6 (69.5–88.9) |
| Spontaneous abortion | |||||
| Primary definition: ≥ 1 inpatient or ≥2 outpatient codes | 100 | 79 | 79.0 (69.7–86.5) | ||
| Exclude cases with codes for other pregnancy outcomes within ±5 days | 59 | 59.0% | 51 | 64.6% | 86.4 (75.0–94.0) |
| Secondary definition: ≥ 1 inpatient or outpatient codes | 250 | 193 | 77.2 (71.5–82.3) | ||
| Exclude cases with codes for other pregnancy outcomes within ±5 days | 171 | 68.4% | 148 | 76.7% | 86.6 (80.5–91.3) |
| Termination | |||||
| Primary definition: ≥ 1 inpatient or ≥2 outpatient codes | 100 | 93 | 93.0 (86.1–97.1) | ||
| Exclude cases with codes for other pregnancy outcomes within ±5 days | 85 | 85.0% | 83 | 89.2% | 97.7 (91.8–99.7) |
| Secondary definition: ≥ 1 inpatient or outpatient codes | 277 | 234 | 84.5 (79.7–88.5) | ||
| Exclude cases with codes for other pregnancy outcomes within ±5 days | 217 | 78.3% | 206 | 88.0% | 94.9 (91.1–97.4) |
| Composite non-live birth outcomes | |||||
| Primary definition | 297a | 274 | 92.3 (88.6–95.0) | ||
| Secondary definition | 623b | 588 | 94.4 (92.3–96.1) |
Out of 300 potential non-live birth cases, 3 duplicates were removed as they were selected for more than one non-live birth sample for validation. This duplication occurred because each non-livebirth cohort was created independently, and codes indicative of different non-live birth outcomes could have been recorded close in time. For the composite non-live birth outcome, a case was considered to be a true positive as long as the non-live birth outcome was confirmed, regardless of the specific type of non-live birth.
Out of 627 potential non-live birth cases, 4 duplicates were removed as they were selected for more than one non-live birth sample for validation.